HCA director Crofton to retire at April 2025 annual meeting; exec incentive program adopted

HCA Healthcare, Inc.

Meg G. Crofton to retire from HCA board effective April 24, 2025 annual meeting.
Compensation Committee adopted 2025 Executive Officer Performance Excellence Program for named execs.
CEO Hazen target award 175% of base salary; CFO Marks and COO Foster 125%.
Awards weighted 80% EBITDA and 20% quality metrics (HAI, sepsis, mortality, care experience).
EBITDA portion: threshold 25%, target 100%, max 200% of target; quality metrics similar but no payout if EBITDA <90% of target.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Meg G. Crofton

Director

HCA · HCA Healthcare, Inc.

Filed: February 24, 2025, 6:59 PM ET

Retirement of Meg G. Crofton from the

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Meg G. Crofton retired as Director at HCA Healthcare, Inc..

Action: retired
Role: Director

Exact text from the filing

Retirement of Meg G. Crofton from the

View on SEC.gov

HCA Healthcare, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-033430

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.